Home » Newsletters » BioWorld Science

BioWorld Science

April 13, 2006

View Archived Issues

Snapshots of histone deacetylases (HDACs) as novel effective targets in cancer therapy: Part I

Galenea to focus on development of drugs to treat CNS diseases

DOR advances mucosal vaccine for botulinum toxin

PPARgamma agonists in cancer highlighted at AACR

Dosing completed in phase I study of Sinovac's H5N1 vaccine

Promising results seen with denosumab in postmenopausal osteoporosis

STRIDE studies reveal effects of sitaxsentan in pulmonary arterial hypertension

MPC-7869 beneficial in patients with mild, but not moderate, Alzheimer's disease

MBP-8298 delays multiple sclerosis progression

XP-13512 significantly improves restless legs syndrome

Garenoxacin effective in community-acquired pneumonia caused by resistant strains

Enrollment ahead of schedule in phase III study of VP-4896 for Alzheimer's

ProMetic begins enrollment in phase Ib/II study of PBI-1402

AlphaRx grants Proprius rights to Indaflex

Emisphere expands enrollment in phase II oral insulin trial

Phase II study of Aridol for COPD completes enrollment

Myriad Genetics and Abbott establish broad drug discovery collaboration

Schering-Plough selects compound from Pharmacopeia collaboration

Tostrex completes European MRP

Expansion of Biolex's collaboration with Medarex

Affymax studies Hematide in pure red cell aplasia patients

Amigal recommended for European orphan drug status for Fabry's disease

Preclinical update on ARRY-142886

Small-molecule pan-ErbB inhibitor selected by J&J as development candidate

Novel analgesic agents reported in recent patents

New AIDS diagnostic developed by Bio-Rad Pasteur

Recent patents describe novel agents for neurological disorders

mTOR inhibitor from Biotica shows potential for glioblastoma multiforme

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...